Clinical Trial Update: Secretin Activates Human Brown Fat and Induces Satiation. [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial investigating secretin for obesity showed activation of human brown fat and increased satiation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Secretin (secretin)

Snippet

Sponsor: Turku University Hospital | Conditions: Obesity | Phase 2, Phase 3 | Status: COMPLETED